Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas

Male 0301 basic medicine Science Programmed Cell Death 1 Receptor Antibodies, Monoclonal, Humanized Article Mice 03 medical and health sciences Drug Delivery Systems Cell Line, Tumor Animals Humans Immune Checkpoint Inhibitors Microbubbles Brain Neoplasms Q Brain Glioma Mice, Inbred C57BL Ultrasonic Waves Doxorubicin Blood-Brain Barrier Female Microglia Glioblastoma
DOI: 10.1038/s41467-024-48326-w Publication Date: 2024-06-06T10:03:47Z
ABSTRACT
Abstract Given the marginal penetration of most drugs across blood-brain barrier, efficacy various agents remains limited for glioblastoma (GBM). Here we employ low-intensity pulsed ultrasound (LIPU) and intravenously administered microbubbles (MB) to open barrier increase concentration liposomal doxorubicin PD-1 blocking antibodies (aPD-1). We report results on a cohort 4 GBM patients preclinical models treated with this approach. LIPU/MB increases by 2-fold 3.9-fold in human murine brains two days after sonication, respectively. Similarly, LIPU/MB-mediated disruption leads 6-fold aPD-1 concentrations peritumoral brain regions from pembrolizumab, Doxorubicin delivered upregulate major histocompatibility complex (MHC) class I II tumor cells. Increased achieved elicit IFN-γ MHC expression microglia macrophages. long-term survival glioma-bearing mice, which rely myeloid cells lymphocytes their efficacy. Overall, translational study supports utility potentiate antitumoral activities GBM.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (78)
CITATIONS (31)